Shares of Marvell Technology (MRVL) declined 7.6% during pre-market activity Monday following a weekend essay from Anthropic CEO Dario Amodei advocating for a measured pause in advanced AI development.
Marvell Technology, Inc., MRVL
The suggestion rapidly gained momentum as prominent industry figures weighed in. Both OpenAI’s Sam Altman and Elon Musk publicly backed the concept, transforming an individual viewpoint into what appeared to be a broader industry consensus.
Investors reacted swiftly. Marvell’s investment thesis hinges heavily on AI infrastructure expansion, specialized processors, and data center growth, making any legitimate concerns about AI capital expenditure particularly damaging to the stock.
The downturn extended well beyond Marvell. Asian chip manufacturers experienced sharp declines during overnight sessions, while European semiconductor equipment producers posted significant losses ahead of U.S. market opening. The tech-heavy Nasdaq declined 1.9%, underscoring the sector-focused nature of the selloff.
Both the S&P 500 and Dow Jones Industrial Average recorded more modest declines. Notably, enterprise software equities gained ground as capital rotated away from hardware and semiconductor names.
An impending Federal Reserve rate announcement compounded the pressure. Markets had largely anticipated the central bank’s action, which typically weighs more heavily on technology stocks trading at elevated multiples. MRVL, commanding a premium valuation, found itself particularly vulnerable.
Despite market turbulence, Bank of America hasn’t wavered from its optimistic outlook. The firm reaffirmed its Buy rating and $365 price objective for MRVL after a management meeting with CEO Matt Murphy and CFO Dan Durn. That target suggests approximately 55% potential appreciation from MRVL’s September 11 close of $236.10.
Analyst Vivek Arya’s confidence stems from Marvell’s product portfolio beyond custom processors. The complementary chips handling connectivity, memory management, and data transfer prove more difficult for clients to develop internally. Marvell currently supplies these components to all four leading U.S. cloud providers, with each custom chip necessitating one or two ancillary products priced between $500 and $1,500.
BofA projects the supporting chip market could exceed $60-65 billion by decade’s end. Capturing 40-50% market share would deliver approximately $30 billion in annual revenue for Marvell from this segment alone, substantially surpassing management’s $3-4 billion-plus projection for 2028.
Including custom processors, BofA envisions a combined revenue opportunity of $40-45 billion by 2030.
However, meaningful risks persist. BofA highlights uncertainty surrounding next-generation chip projects from Amazon and Microsoft. Any postponements could defer revenue recognition and weaken the earnings trajectory supporting current valuations.
Broadcom represents the primary competitive challenge in customized chip development.
The Google collaboration, frequently highlighted as a strategic milestone, operates under a purchase-linked structure rather than firm commitments. Approximately 59 million warrants may also be exercised, introducing possible shareholder dilution.
MRVL’s October 6 analyst day will draw considerable attention. Market participants will seek concrete details regarding production schedules, profitability projections, and customer deployment timelines. Prior to Monday’s retreat, MRVL stock had rallied over 160% during the preceding six months, advancing nearly 12% through September 11 while Nvidia declined more than 5% during the same period.
The post Marvell (MRVL) Stock Tumbles 7.6% as Anthropic CEO Proposes AI Development Pause appeared first on Blockonomi.
